Allegra C - Search Results

1

The prognostic value of molecular marker analysis in patients treated with trimodality therapy for esophageal cancer.

Harpole DH Jr, Moore MB, Herndon JE 2nd, Aloia T, D'Amico TA, Sporn T, Parr A, Linoila I, Allegra C. Harpole DH Jr, et al. Among authors: allegra c. Clin Cancer Res. 2001 Mar;7(3):562-9. Clin Cancer Res. 2001. PMID: 11297249

2

The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer.

Johnston PG, Fisher ER, Rockette HE, Fisher B, Wolmark N, Drake JC, Chabner BA, Allegra CJ. Johnston PG, et al. Among authors: allegra cj. J Clin Oncol. 1994 Dec;12(12):2640-7. doi: 10.1200/JCO.1994.12.12.2640. J Clin Oncol. 1994. PMID: 7989939 Clinical Trial.

3

Prognostic importance of thymidylate synthase expression in early breast cancer.

Pestalozzi BC, Peterson HF, Gelber RD, Goldhirsch A, Gusterson BA, Trihia H, Lindtner J, Cortés-Funes H, Simmoncini E, Byrne MJ, Golouh R, Rudenstam CM, Castiglione-Gertsch M, Allegra CJ, Johnston PG. Pestalozzi BC, et al. Among authors: allegra cj. J Clin Oncol. 1997 May;15(5):1923-31. doi: 10.1200/JCO.1997.15.5.1923. J Clin Oncol. 1997. PMID: 9164203 Clinical Trial.

4

5-fluorouracil-mediated thymidylate synthase induction in malignant and nonmalignant human cells.

Parr AL, Drake JC, Gress RE, Schwartz G, Steinberg SM, Allegra CJ. Parr AL, et al. Among authors: allegra cj. Biochem Pharmacol. 1998 Jul 15;56(2):231-5. doi: 10.1016/s0006-2952(98)00152-x. Biochem Pharmacol. 1998. PMID: 9698077

5

Thymidine kinase, thymidylate synthase, and dihydropyrimidine dehydrogenase profiles of cell lines of the National Cancer Institute's Anticancer Drug Screen.

Grem JL, Danenberg KD, Behan K, Parr A, Young L, Danenberg PV, Nguyen D, Drake J, Monks A, Allegra CJ. Grem JL, et al. Among authors: allegra cj. Clin Cancer Res. 2001 Apr;7(4):999-1009. Clin Cancer Res. 2001. PMID: 11309351

6

Development of human anti-thymidine kinase antibodies.

Voeller DM, Parr A, Allegra CJ. Voeller DM, et al. Among authors: allegra cj. Anticancer Drugs. 2001 Jul;12(6):555-9. doi: 10.1097/00001813-200107000-00010. Anticancer Drugs. 2001. PMID: 11460003 No abstract available.

7

Thymidylate synthase as a molecular target for drug discovery using the National Cancer Institute's Anticancer Drug Screen.

Parr AL, Myers TG, Holbeck SL, Loh YJ, Allegra CJ. Parr AL, et al. Among authors: allegra cj. Anticancer Drugs. 2001 Aug;12(7):569-74. doi: 10.1097/00001813-200108000-00002. Anticancer Drugs. 2001. PMID: 11487712

8

Tumor marker expression is predictive of survival in patients with esophageal cancer.

Aloia TA, Harpole DH Jr, Reed CE, Allegra C, Moore MB, Herndon JE 2nd, D'Amico TA. Aloia TA, et al. Among authors: allegra c. Ann Thorac Surg. 2001 Sep;72(3):859-66. doi: 10.1016/s0003-4975(01)02838-7. Ann Thorac Surg. 2001. PMID: 11565671

9

Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer.

Allegra CJ, Parr AL, Wold LE, Mahoney MR, Sargent DJ, Johnston P, Klein P, Behan K, O'Connell MJ, Levitt R, Kugler JW, Tria Tirona M, Goldberg RM. Allegra CJ, et al. J Clin Oncol. 2002 Apr 1;20(7):1735-43. doi: 10.1200/JCO.2002.07.080. J Clin Oncol. 2002. PMID: 11919229

10

Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study.

Allegra CJ, Paik S, Colangelo LH, Parr AL, Kirsch I, Kim G, Klein P, Johnston PG, Wolmark N, Wieand HS. Allegra CJ, et al. J Clin Oncol. 2003 Jan 15;21(2):241-50. doi: 10.1200/JCO.2003.05.044. J Clin Oncol. 2003. PMID: 12525515 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

335 results

Search Page